Brief: Aileron Therapeutics Reports First Quarter 2022 Financial Results
05/05/2022 21:47
May 5 (Reuters) - Aileron Therapeutics Inc ALRN.O :
* AILERON THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
* AILERON THERAPEUTICS INC - CASH RUNWAY INTO Q4 OF 2023
* AILERON THERAPEUTICS INC - BASIC AND DILUTED NET LOSS PER
SHARE
FOR Q1 OF 2022 WAS $0.09
Source text for Eikon: ID:nGNX4p0JFJ
Further company coverage: ALRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering